Yumanity Therapeutics announced the appointment of Paulash Mohsen as chief business officer. Mr. Mohsen joins Yumanity from Cubist Pharmaceuticals where he most recently served as country manager in Canada, leading the company's first international operation from conceptualization through commercialization. In this role, he led the launch of DIFICID (fidaxomicin) in Canada and oversaw the company's commercial, scientific and general and administrative functions.

Prior to that, Mr. Mohsen was vice president, strategy and business operations for Optimer Pharmaceuticals and helped establish the commercial infrastructure and led U.S. launch preparedness for DIFICID.